Peptides: what's proven and what isn't
Peptides are all over social media, sold for healing, recovery and anti-aging. Some are among the best-proven medicines we have. Others are untested chemicals in a vial.
Has this specific product been properly tested in people, and do you know what is in the vial?
The short version
- Peptides are not one thing. Some are among the best-proven medicines we have. Others are untested chemicals sold online.
- The peptides promoted for “healing,” “recovery,” and “anti-aging” (BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, epitalon and others) have little or no controlled human evidence of benefit.
- The best-documented risk is the product itself. Vials bought online may contain the wrong dose, impurities, or contaminants.
- Easy to buy is not the same as safe. Being easy to buy, or legal to compound, is not proof that something is safe or works.
What is a peptide?
A peptide is a short chain of amino acids, the same building blocks that make up proteins. Your body makes thousands of them, and many act as chemical messengers.
Several peptides are well-tested prescription medicines: insulin, the GLP-1 medicines for diabetes and weight (semaglutide, tirzepatide), and others. These went through large clinical trials. Tirzepatide, for example, was studied in more than 7,700 people before approval (Mavrych et al., Frontiers in Aging, 2026).
So the question is never “are peptides good or bad?” The question is: has this specific product been properly tested in people, and do I know what is in the vial?
Three very different categories
- 1FDA-approved peptide medicines. Tested in large trials for a specific condition, made under strict manufacturing standards, prescribed and monitored by a clinician.
- 2Compounded peptides. Mixed by a compounding pharmacy on prescription. These products are not reviewed by the FDA for safety, effectiveness, or quality.
- 3“Research use only” peptides. Sold online, often labeled “not for human use,” then marketed on social media for exactly that. There is no oversight of what is in the vial. Peptide hashtags had more than 230 million TikTok views by May 2026 (Piatkowski et al., JAMA, 2026). Popularity is not evidence.
The most commonly sold peptides
- Marketed for
- Tendon, muscle, and gut healing
- What human studies show
- Many animal studies. In people: only three small pilot studies and no rigorous trials (Janovsky, JAMA, 2026).
- Main concerns
- Stimulates new blood vessel growth, which raises a theoretical cancer concern. Long-term safety unknown.
- Marketed for
- Injury recovery
- What human studies show
- No human studies of benefit. It is a small fragment of a natural protein (thymosin beta-4) and has not been shown to act the same way (Tham et al., Journal of the American Academy of Orthopaedic Surgeons, 2026).
- Main concerns
- Untested in people.
- Marketed for
- Skin, hair, healing
- What human studies show
- Some evidence as a skin cream or serum. A 2026 systematic review found only 2 randomized trials, both cosmetic (Mokhtar et al., Aesthetic Surgery Journal, 2026).
- Main concerns
- Injected use is untested and adds copper exposure. Topical use is low risk.
- Marketed for
- Muscle gain, fat loss, “anti-aging”
- What human studies show
- They raise growth hormone levels. No trials show better strength, function, or healthy aging. In one early trial, side effects occurred in 94% of people on CJC-1295 versus 29% on placebo, and a later trial was stopped after a participant died, although the drug’s role was never established (Mendias and Awan, Sports Medicine, 2026).
- Main concerns
- Chronically raised growth hormone can cause fluid retention and insulin resistance.
- Marketed for
- Fat loss, “anti-aging”
- What human studies show
- Tesamorelin is FDA-approved only to reduce belly fat in people with HIV-related lipodystrophy. Six weeks of sermorelin did not change weight or body composition (Mendias and Awan, Sports Medicine, 2026).
- Main concerns
- Same growth hormone concerns. Not tested for healthy aging.
- Marketed for
- Energy, metabolism, “exercise in a vial”
- What human studies show
- Mouse studies. In people, we only know that natural levels rise after exercise (Gunawan et al., EMBO Journal, 2025).
- Main concerns
- No human treatment trials.
- Marketed for
- Mitochondria, energy
- What human studies show
- FDA-approved only for Barth syndrome, a rare genetic disease.
- Main concerns
- Not studied for wellness in healthy people.
- Marketed for
- Telomeres, longevity
- What human studies show
- Lab and animal studies, plus small studies from Russia that have not been independently confirmed (Mavrych et al., Frontiers in Aging, 2026).
- Main concerns
- In lab studies it lengthened telomeres in cancer cells as well as normal cells (Al-Dulaimi et al., Biogerontology, 2025).
- Marketed for
- Focus, memory
- What human studies show
- Russian studies in stroke patients. No independent confirmation and no trials in healthy adults (Mavrych et al., Frontiers in Aging, 2026).
- Main concerns
- Unknown long-term safety.
- Marketed for
- Tanning
- What human studies show
- Not approved anywhere for tanning.
- Main concerns
- Darkening moles and new atypical moles. Case reports of melanoma during or soon after use, although cause and effect is unproven (Habbema et al., International Journal of Dermatology, 2017). One reported overdose caused muscle breakdown and kidney injury (Nelson et al., Clinical Toxicology, 2012).
- Marketed for
- Libido
- What human studies show
- FDA-approved as Vyleesi only for premenopausal women with low sexual desire disorder. Not approved for men or to enhance performance.
- Main concerns
- Online versions are not the approved product.
- Marketed for
- Weight loss
- What human studies show
- The FDA-approved versions work and are well studied. The concern is the source.
- Main concerns
- See “The vial problem” below.
- Marketed for
- Skin, joints
- What human studies show
- A food supplement, not an injection. A meta-analysis of 23 randomized trials found skin benefits only in industry-funded and lower-quality studies (Myung and Park, American Journal of Medicine, 2025).
- Main concerns
- Low risk. Benefit for skin is unproven.
- Marketed for
- Energy, anti-aging
- What human studies show
- Not a peptide, but sold alongside them. A 2026 systematic review found no outcome trials of injected or infused NAD+ for anti-aging or wellness (Gallagher and Emmanuel, Ageing Research Reviews, 2026).
- Main concerns
- Cost. Infusion reactions.
Why “it worked in mice” is not enough
Almost every peptide in the table has encouraging laboratory or animal data. That is where all medicines start, and most of them fail once tested in people, either because they do not work or because of side effects that animal studies did not predict.
Personal stories are also unreliable. Injuries heal on their own, people change their training and diet at the same time, and the placebo effect of an injection is strong.
The vial problem
Even if a peptide were proven to work, you would still need to trust what is in the vial.
- Purity and contamination. When scientists tested peptides bought from illegal internet sellers, purity for some ranged from 5% to 75%, and some samples contained arsenic and lead, with levels up to ten times the safety limit for injected drugs (Janvier et al., Talanta, 2018).
- Wrong dose. Vials sold online as retatrutide contained from about half to almost double the labeled amount (Piatkowski et al., JAMA, 2026).
- Dosing errors. With compounded semaglutide, the FDA has received reports of people accidentally injecting 5 to 20 times the intended dose, some needing hospital care (Neumiller et al., American Diabetes Association statement, 2025).
- Sterility. Mixing powders with water at home and injecting them carries a risk of infection.
For these reasons, the American Diabetes Association recommends using FDA-approved medicines rather than compounded versions.
“But they are becoming legal”
The rules are changing, and this causes understandable confusion.
- 2023: the FDA restricted pharmacy compounding of several of these peptides because of safety concerns, including impurities and immune reactions.
- 2026: the agency began reversing course. In July 2026 an FDA advisory committee voted to allow compounding of six peptides, including BPC-157, TB-500, MOTS-c, semax, and epitalon. The FDA’s own scientists had reviewed the evidence and recommended against all of them (Samantaroy et al., JAMA, 2026).
- No new human trials drove this change.
A change in the rules does not change the evidence. Wider access means more people will be offered these products, not that they have been shown to be safe or to work.
What actually works
The things with the strongest evidence for a longer, healthier life are not sold in vials: regular aerobic and strength exercise, not smoking, good sleep, a mostly whole-food diet, limiting alcohol, staying socially connected, and controlling blood pressure, cholesterol, and blood sugar. Recommended vaccines and cancer screening belong on that list too.
Before spending money on an unproven injection, it is worth asking whether those basics are fully in place.
Five questions to ask before buying any peptide
- 1Is it FDA-approved for the reason I want to use it?
- 2Has it been tested against placebo in people, or only in animals?
- 3Who made it, and has the vial been independently tested?
- 4Who will monitor me, and what happens if something goes wrong?
- 5Does the person recommending it earn money from selling it?
If you are already using a peptide
- Tell your clinician. It's better they know, and it helps them interpret your symptoms and lab results.
- Seek care promptly for fever, a red, hot or swollen injection site, chest pain, palpitations, severe headache, persistent vomiting, or a new or changing mole.
- Never share vials, needles, or syringes.
- Take extra care if you have had cancer, are pregnant or trying to conceive, or take several medications. These groups have the most to lose from an untested product.
- Competitive athletes: many of these substances are prohibited in tested sport.
Our position
We prescribe peptide medicines when they are approved and proven. We do not recommend unapproved injectable peptides for healing, performance, or anti-aging, because the evidence of benefit is not there and the product risks are real. If that changes for any of them, we will update this page.
Questions about something you have seen or been offered? Bring it to your next visit, including the label if you have it.
Selected sources
- Piatkowski et al. JAMA, 2026.
- Janovsky. JAMA, 2026.
- Samantaroy et al. JAMA, 2026.
- Mavrych et al. Frontiers in Aging, 2026.
- Mendias and Awan. Sports Medicine, 2026.
- Tham et al. Journal of the American Academy of Orthopaedic Surgeons, 2026.
- Mokhtar et al. Aesthetic Surgery Journal, 2026.
- Gallagher and Emmanuel. Ageing Research Reviews, 2026.
- Gunawan et al. EMBO Journal, 2025.
- Al-Dulaimi et al. Biogerontology, 2025.
- Myung and Park. American Journal of Medicine, 2025.
- Neumiller et al. American Diabetes Association statement on compounded GLP-1 medicines, 2025.
- Janvier et al. Talanta, 2018.
- Habbema et al. International Journal of Dermatology, 2017.
- Nelson et al. Clinical Toxicology, 2012.
Last reviewed November 2026. This article is general education, not personal medical advice. Talk with your own clinician before starting, stopping, or changing any medicine or product.
Help fund screening for othersWe're planning a fund for cancer screening and heart disease prevention for people who can't afford them. Let us know if you'd be interested.Read nextSupplements are not harmlessSome cause harm. Most do nothing at all.